News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
730,143 Results
Type
Article (41328)
Company Profile (265)
Press Release (688533)
Multimedia
Podcasts (91)
Webinars (20)
Section
Business (204834)
Career Advice (2031)
Deals (35579)
Drug Delivery (128)
Drug Development (81507)
Employer Resources (173)
FDA (16503)
Job Trends (14979)
News (346795)
Policy (32750)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2593)
Accelerated approval (46)
Adcomms (26)
Allergies (170)
Alliances (49579)
ALS (210)
Alzheimer's disease (1782)
Antibody-drug conjugate (ADC) (440)
Approvals (16875)
Artificial intelligence (650)
Autoimmune disease (280)
Automation (54)
Bankruptcy (362)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (219)
Biotechnology (175)
Bladder cancer (186)
Brain cancer (70)
Breast cancer (743)
Cancer (5753)
Cardiovascular disease (466)
Career advice (1723)
Career pathing (41)
CAR-T (327)
CDC (56)
Celiac Disease (3)
Cell therapy (883)
Cervical cancer (47)
Clinical research (70732)
Collaboration (2032)
Company closure (5)
Compensation (1380)
Complete response letters (78)
COVID-19 (2740)
CRISPR (107)
C-suite (1105)
Cystic fibrosis (151)
Data (7750)
Decentralized trials (3)
Denatured (27)
Depression (159)
Dermatology (83)
Diabetes (584)
Diagnostics (6915)
Digital health (54)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (313)
Drug pricing (200)
Drug shortages (31)
Duchenne muscular dystrophy (280)
Earnings (91893)
Editorial (66)
Employer branding (21)
Employer resources (152)
Events (119344)
Executive appointments (1075)
FDA (20191)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (34)
Funding (1703)
Gene editing (232)
Generative AI (55)
Gene therapy (711)
GLP-1 (1048)
Government (4728)
Grass and pollen (6)
Guidances (408)
Healthcare (18985)
HIV (79)
Huntington's disease (56)
IgA nephropathy (96)
Immunology and inflammation (285)
Immuno-oncology (91)
Indications (188)
Infectious disease (3077)
Inflammatory bowel disease (216)
Inflation Reduction Act (14)
Influenza (136)
Intellectual property (288)
Interviews (319)
IPO (16666)
IRA (50)
Job creations (3646)
Job search strategy (1430)
JPM (58)
Kidney cancer (19)
Labor market (98)
Layoffs (561)
Leadership (38)
Legal (7953)
Liver cancer (99)
Longevity (32)
Lung cancer (757)
Lymphoma (426)
Machine learning (59)
Management (59)
Manufacturing (1028)
MASH (183)
Medical device (13918)
Medtech (14035)
Mergers & acquisitions (20152)
Metabolic disorders (1484)
mRNA (203)
Multiple sclerosis (187)
NASH (17)
Neurodegenerative disease (411)
Neuropsychiatric disorders (105)
Neuroscience (3278)
Neurotech (1)
NextGen: Class of 2026 (6521)
Non-profit (4530)
Now hiring (77)
Obesity (695)
Opinion (285)
Ovarian cancer (218)
Pain (250)
Pancreatic cancer (294)
Parkinson's disease (356)
Partnered (33)
Patents (592)
Patient recruitment (665)
Peanut (62)
People (59539)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (22046)
Phase 2 (31159)
Phase 3 (23191)
Pipeline (8446)
Policy (313)
Postmarket research (2568)
Preclinical (9390)
Press Release (64)
Prostate cancer (293)
Psychedelics (54)
Radiopharmaceuticals (319)
Rare diseases (1063)
Real estate (5968)
Recruiting (70)
Regulatory (25355)
Reports (56)
Research institute (2412)
Resumes & cover letters (353)
Rett syndrome (38)
RNA editing (21)
RSV (88)
Schizophrenia (176)
Series A (286)
Series B (210)
Service/supplier (11)
Sickle cell disease (111)
Special edition (23)
Spinal muscular atrophy (165)
Sponsored (48)
Startups (3638)
State (2)
Stomach cancer (18)
Supply chain (126)
Tariffs (87)
The Weekly (62)
Vaccines (1088)
Venture capital (107)
Weight loss (447)
Women's health (124)
Worklife (20)
Date
Today (206)
Last 7 days (934)
Last 30 days (3408)
Last 365 days (30223)
2026 (11894)
2025 (30170)
2024 (35211)
2023 (40072)
2022 (51173)
2021 (55707)
2020 (54081)
2019 (46537)
2018 (35015)
2017 (32107)
2016 (31479)
2015 (37551)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (741)
Alabama (91)
Alaska (7)
Arizona (347)
Arkansas (14)
Asia (39644)
Australia (6499)
California (13119)
Canada (3722)
China (1322)
Colorado (562)
Connecticut (571)
Delaware (400)
Europe (85779)
Florida (1961)
Georgia (420)
Hawaii (3)
Idaho (62)
Illinois (1044)
India (88)
Indiana (596)
Iowa (23)
Japan (529)
Kansas (130)
Kentucky (50)
Louisiana (40)
Maine (75)
Maryland (1576)
Massachusetts (9365)
Michigan (358)
Minnesota (707)
Mississippi (6)
Missouri (143)
Montana (33)
Nebraska (29)
Nevada (140)
New Hampshire (84)
New Jersey (3452)
New Mexico (29)
New York (3430)
North Carolina (1663)
North Dakota (9)
Northern California (6567)
Ohio (393)
Oklahoma (23)
Oregon (41)
Pennsylvania (2636)
Puerto Rico (29)
Rhode Island (50)
South America (1112)
South Carolina (85)
South Dakota (2)
Southern California (5174)
Tennessee (209)
Texas (2084)
United States (46294)
Utah (392)
Vermont (1)
Virginia (316)
Washington D.C. (80)
Washington State (1051)
West Virginia (4)
Wisconsin (124)
Wyoming (2)
730,143 Results for "encision inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Encision Inc. Announces Fiscal 2026 Fourth Quarter and Full Year Results
April 14, 2026
·
2 min read
Press Releases
Encision Inc. Announces Fiscal 2026 Third Quarter Results
February 4, 2026
·
1 min read
Press Releases
Encision Deregisters Common Stock
January 29, 2026
·
2 min read
Press Releases
Encision Reports Second Quarter Fiscal Year 2026 Results
November 14, 2025
·
6 min read
Press Releases
Encision Reports First Quarter Fiscal Year 2026 Results
August 15, 2025
·
5 min read
Press Releases
Encision Reports Fourth Quarter Fiscal Year 2025 Results
July 11, 2025
·
6 min read
Press Releases
Encision Signs Master Services Agreement with Vicarious Surgical Inc.
August 21, 2024
·
2 min read
Business
Encision Reports Third Quarter Fiscal Year 2024 Results
Encision Inc., a medical device company owning patented Active Electrode Monitoring Technology that prevents dangerous radiant energy burns in minimally invasive surgery, announced financial results for its fiscal 2024 third quarter that ended December 31, 2023.
February 14, 2024
·
6 min read
Press Releases
Encision Reports Third Quarter Fiscal Year 2025 Results
February 17, 2025
·
7 min read
BioMidwest
Encision Signs Proof of Concept Agreement with Vicarious Surgical Inc.
Encision Inc., a medical device company owning patented Active Electrode Monitoring Technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, announced that Encision has signed a Proof of Concept Services Agreement with Vicarious Surgical Inc.
February 14, 2023
·
2 min read
1 of 73,015
Next
